| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 23 | 2021 | 724 | 3.730 |
Why?
|
| Interferon Regulatory Factors | 10 | 2020 | 67 | 3.140 |
Why?
|
| Plasma Cells | 7 | 2021 | 80 | 1.730 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 4 | 2020 | 132 | 1.480 |
Why?
|
| Gene Regulatory Networks | 3 | 2020 | 296 | 1.460 |
Why?
|
| Cell Differentiation | 15 | 2021 | 1458 | 1.380 |
Why?
|
| Transplantation Tolerance | 4 | 2020 | 130 | 1.080 |
Why?
|
| Germinal Center | 4 | 2021 | 55 | 0.940 |
Why?
|
| Immunologic Memory | 6 | 2023 | 152 | 0.900 |
Why?
|
| Antibody Formation | 2 | 2020 | 171 | 0.830 |
Why?
|
| Haploinsufficiency | 1 | 2021 | 62 | 0.800 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 1920 | 0.730 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 6 | 1999 | 102 | 0.720 |
Why?
|
| Transcription Factors | 9 | 2020 | 1565 | 0.640 |
Why?
|
| Mice | 27 | 2023 | 11352 | 0.560 |
Why?
|
| Animals | 37 | 2023 | 26582 | 0.550 |
Why?
|
| Graft Rejection | 7 | 2017 | 1065 | 0.540 |
Why?
|
| Signal Transduction | 9 | 2020 | 3241 | 0.530 |
Why?
|
| Immunity, Humoral | 2 | 2017 | 67 | 0.530 |
Why?
|
| Repressor Proteins | 5 | 2006 | 403 | 0.520 |
Why?
|
| Heart Transplantation | 6 | 2017 | 705 | 0.480 |
Why?
|
| Isoantibodies | 5 | 2020 | 114 | 0.450 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2021 | 113 | 0.440 |
Why?
|
| Immunoglobulin Class Switching | 3 | 2022 | 37 | 0.430 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 425 | 0.410 |
Why?
|
| B-Lymphocytes, Regulatory | 1 | 2011 | 8 | 0.410 |
Why?
|
| Organ Transplantation | 2 | 2015 | 265 | 0.410 |
Why?
|
| Antibody Diversity | 1 | 2011 | 25 | 0.400 |
Why?
|
| Genes, Immunoglobulin | 1 | 2011 | 111 | 0.390 |
Why?
|
| Graft Survival | 5 | 2017 | 884 | 0.380 |
Why?
|
| T-Lymphocytes | 6 | 2020 | 1195 | 0.370 |
Why?
|
| Antigens | 3 | 2017 | 228 | 0.340 |
Why?
|
| Mice, Transgenic | 8 | 2021 | 1540 | 0.340 |
Why?
|
| Immune Tolerance | 1 | 2011 | 337 | 0.340 |
Why?
|
| Lymphocyte Activation | 5 | 2016 | 728 | 0.340 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 5 | 2013 | 13 | 0.330 |
Why?
|
| Immunoglobulins | 3 | 2013 | 148 | 0.330 |
Why?
|
| PAX5 Transcription Factor | 2 | 2012 | 32 | 0.310 |
Why?
|
| Mice, Inbred BALB C | 10 | 2020 | 1047 | 0.300 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 559 | 0.300 |
Why?
|
| Cell Lineage | 3 | 2016 | 273 | 0.290 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 1384 | 0.280 |
Why?
|
| Viral Envelope Proteins | 2 | 1998 | 94 | 0.280 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 1208 | 0.280 |
Why?
|
| T-Lymphocyte Subsets | 3 | 1998 | 272 | 0.280 |
Why?
|
| Abatacept | 2 | 2016 | 83 | 0.280 |
Why?
|
| Cytidine Deaminase | 4 | 2022 | 43 | 0.270 |
Why?
|
| Recombination, Genetic | 2 | 2022 | 439 | 0.270 |
Why?
|
| Th2 Cells | 2 | 2020 | 146 | 0.270 |
Why?
|
| Endosomes | 2 | 2017 | 75 | 0.270 |
Why?
|
| Immunosuppressive Agents | 3 | 2016 | 977 | 0.270 |
Why?
|
| CTLA-4 Antigen | 2 | 2016 | 135 | 0.250 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2004 | 40 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 12 | 2017 | 3092 | 0.240 |
Why?
|
| Dendritic Cells | 4 | 2020 | 425 | 0.230 |
Why?
|
| Mice, Knockout | 5 | 2017 | 1924 | 0.220 |
Why?
|
| Ribonucleases | 1 | 2022 | 92 | 0.220 |
Why?
|
| Isoantigens | 2 | 2020 | 66 | 0.210 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2020 | 159 | 0.200 |
Why?
|
| Ikaros Transcription Factor | 1 | 2020 | 25 | 0.190 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2020 | 19 | 0.180 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2017 | 158 | 0.180 |
Why?
|
| Allografts | 3 | 2015 | 172 | 0.180 |
Why?
|
| Th17 Cells | 1 | 2020 | 80 | 0.170 |
Why?
|
| Antigen Presentation | 3 | 1998 | 209 | 0.170 |
Why?
|
| Peptide Fragments | 2 | 2012 | 460 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 1197 | 0.170 |
Why?
|
| Chromatin | 1 | 2021 | 380 | 0.160 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 250 | 0.160 |
Why?
|
| CD79 Antigens | 1 | 2017 | 17 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 14 | 0.160 |
Why?
|
| Encephalitis, Viral | 1 | 1997 | 7 | 0.150 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 47 | 0.150 |
Why?
|
| Ubiquitination | 1 | 2017 | 67 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2012 | 292 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1135 | 0.150 |
Why?
|
| Immunization | 1 | 2017 | 158 | 0.150 |
Why?
|
| Simplexvirus | 2 | 1997 | 151 | 0.150 |
Why?
|
| Humans | 19 | 2022 | 86643 | 0.150 |
Why?
|
| Interleukin-2 | 1 | 2017 | 249 | 0.150 |
Why?
|
| Kidney Transplantation | 2 | 2014 | 849 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1578 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 1998 | 244 | 0.140 |
Why?
|
| Protein Binding | 2 | 2017 | 1456 | 0.140 |
Why?
|
| Protein Conformation | 1 | 1998 | 881 | 0.140 |
Why?
|
| Herpes Simplex | 1 | 1997 | 202 | 0.140 |
Why?
|
| Proteins | 1 | 2021 | 777 | 0.140 |
Why?
|
| Cell Line | 2 | 2017 | 2468 | 0.130 |
Why?
|
| Immunoconjugates | 1 | 2016 | 106 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 372 | 0.130 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2022 | 32 | 0.130 |
Why?
|
| Binding Sites | 1 | 2017 | 1098 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 315 | 0.130 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2014 | 20 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2014 | 36 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1376 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2013 | 14 | 0.120 |
Why?
|
| Vaccines, Subunit | 1 | 2013 | 55 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2013 | 43 | 0.120 |
Why?
|
| CD40 Ligand | 1 | 2013 | 69 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2015 | 232 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 65 | 0.110 |
Why?
|
| Nanofibers | 1 | 2013 | 31 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 41 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 142 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2013 | 62 | 0.110 |
Why?
|
| Neutrophils | 2 | 2012 | 307 | 0.110 |
Why?
|
| Transplantation, Homologous | 4 | 2017 | 996 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2013 | 271 | 0.110 |
Why?
|
| Trans-Activators | 2 | 2013 | 429 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2013 | 167 | 0.110 |
Why?
|
| Interferon-gamma | 3 | 2020 | 444 | 0.110 |
Why?
|
| Protein Kinase C | 1 | 2013 | 270 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 302 | 0.110 |
Why?
|
| Interleukin-7 | 1 | 2012 | 41 | 0.100 |
Why?
|
| Phenotype | 2 | 2016 | 2378 | 0.100 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 2426 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 645 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 114 | 0.100 |
Why?
|
| Mathematical Computing | 1 | 2011 | 21 | 0.100 |
Why?
|
| Myeloid Cells | 1 | 2012 | 98 | 0.100 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2011 | 32 | 0.100 |
Why?
|
| Systems Biology | 1 | 2011 | 42 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 148 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 689 | 0.100 |
Why?
|
| Peptides | 1 | 2013 | 639 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2012 | 464 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2232 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 736 | 0.080 |
Why?
|
| Cell Movement | 2 | 2017 | 758 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 2062 | 0.070 |
Why?
|
| Lung | 1 | 2013 | 1170 | 0.070 |
Why?
|
| Male | 7 | 2020 | 40965 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 2818 | 0.070 |
Why?
|
| Female | 7 | 2020 | 44532 | 0.070 |
Why?
|
| Endocytosis | 2 | 2017 | 177 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 955 | 0.060 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 456 | 0.060 |
Why?
|
| Germ Cells | 1 | 2005 | 126 | 0.060 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 116 | 0.060 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 92 | 0.060 |
Why?
|
| Models, Biological | 1 | 2011 | 1749 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2004 | 153 | 0.060 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 111 | 0.060 |
Why?
|
| CD18 Antigens | 1 | 2023 | 22 | 0.060 |
Why?
|
| Algorithms | 1 | 2011 | 1830 | 0.060 |
Why?
|
| Genome | 1 | 2006 | 372 | 0.060 |
Why?
|
| Body Patterning | 1 | 2005 | 209 | 0.060 |
Why?
|
| Cytokines | 2 | 2020 | 776 | 0.060 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 105 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2004 | 420 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2022 | 79 | 0.050 |
Why?
|
| Lymphoma | 1 | 2004 | 262 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2015 | 7993 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 92 | 0.050 |
Why?
|
| Culture Media | 1 | 2021 | 147 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2004 | 447 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 104 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2021 | 103 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1753 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 1294 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2020 | 31 | 0.050 |
Why?
|
| Inflammation | 3 | 2013 | 920 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 685 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 196 | 0.040 |
Why?
|
| Cyclic AMP | 1 | 2020 | 273 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 1998 | 16 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 1998 | 18 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 1998 | 30 | 0.040 |
Why?
|
| Monocytes | 1 | 2020 | 214 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 286 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1998 | 47 | 0.040 |
Why?
|
| CHO Cells | 1 | 1998 | 187 | 0.040 |
Why?
|
| Clone Cells | 1 | 1998 | 213 | 0.040 |
Why?
|
| Virus Diseases | 1 | 1999 | 97 | 0.040 |
Why?
|
| Viruses | 1 | 1999 | 78 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 1998 | 89 | 0.040 |
Why?
|
| Liver | 1 | 2023 | 1230 | 0.040 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 15 | 0.040 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2017 | 54 | 0.040 |
Why?
|
| Cricetinae | 1 | 1998 | 560 | 0.040 |
Why?
|
| Granzymes | 1 | 2017 | 93 | 0.040 |
Why?
|
| Keratitis, Herpetic | 1 | 1997 | 9 | 0.040 |
Why?
|
| Trigeminal Ganglion | 1 | 1997 | 16 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2017 | 93 | 0.040 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 92 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2017 | 101 | 0.040 |
Why?
|
| Cell Tracking | 1 | 2016 | 14 | 0.040 |
Why?
|
| Integrases | 1 | 2016 | 59 | 0.040 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 63 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 144 | 0.030 |
Why?
|
| Programmed Cell Death 1 Ligand 2 Protein | 1 | 2015 | 10 | 0.030 |
Why?
|
| 5'-Nucleotidase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Virus Replication | 1 | 1997 | 319 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 916 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2014 | 77 | 0.030 |
Why?
|
| Schistosomiasis | 1 | 1994 | 5 | 0.030 |
Why?
|
| Thy-1 Antigens | 1 | 1994 | 16 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1538 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1994 | 100 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 94 | 0.030 |
Why?
|
| Alum Compounds | 1 | 2013 | 5 | 0.030 |
Why?
|
| Protein Kinase C-theta | 1 | 2013 | 16 | 0.030 |
Why?
|
| B7-2 Antigen | 1 | 2013 | 40 | 0.030 |
Why?
|
| Arthritis | 1 | 1994 | 46 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1994 | 80 | 0.030 |
Why?
|
| B7-1 Antigen | 1 | 2013 | 75 | 0.030 |
Why?
|
| Listeriosis | 1 | 1994 | 84 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 78 | 0.030 |
Why?
|
| Mites | 1 | 2013 | 16 | 0.030 |
Why?
|
| Rituximab | 1 | 2013 | 116 | 0.030 |
Why?
|
| Cyclosporine | 1 | 1994 | 234 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 88 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 165 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 430 | 0.030 |
Why?
|
| Epitopes | 1 | 2013 | 255 | 0.030 |
Why?
|
| Syndecan-1 | 1 | 2012 | 13 | 0.030 |
Why?
|
| Antigens, CD20 | 1 | 2012 | 36 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 293 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 411 | 0.030 |
Why?
|
| Complement C4b | 1 | 2012 | 35 | 0.030 |
Why?
|
| Collagen | 1 | 1994 | 269 | 0.030 |
Why?
|
| CD3 Complex | 1 | 2012 | 135 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 23 | 0.030 |
Why?
|
| Interleukins | 1 | 2013 | 134 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2013 | 149 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2011 | 18 | 0.030 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 193 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2011 | 45 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 253 | 0.030 |
Why?
|
| Genotype | 1 | 2016 | 1851 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2012 | 163 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 166 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2012 | 384 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2011 | 144 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2016 | 864 | 0.020 |
Why?
|
| Base Sequence | 1 | 1994 | 2330 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 444 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 859 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 615 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3030 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 298 | 0.020 |
Why?
|
| Biopsy | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 937 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5210 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2006 | 17 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 190 | 0.020 |
Why?
|
| DNA, Single-Stranded | 1 | 2006 | 92 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4213 | 0.020 |
Why?
|
| Limb Buds | 1 | 2005 | 6 | 0.020 |
Why?
|
| Branchial Region | 1 | 2005 | 10 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 547 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 25028 | 0.020 |
Why?
|
| Adult | 2 | 2014 | 25648 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 421 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2006 | 482 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 596 | 0.010 |
Why?
|
| Placenta | 1 | 2005 | 175 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 554 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 268 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 532 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1995 | 20 | 0.010 |
Why?
|
| Lymphokines | 1 | 1995 | 76 | 0.010 |
Why?
|
| CD28 Antigens | 1 | 1995 | 88 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 81 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 347 | 0.010 |
Why?
|
| Immunity | 1 | 1995 | 136 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 1995 | 179 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1995 | 203 | 0.010 |
Why?
|